Migraine Headaches Study
- August 2, 2018
The purpose of this study is to evaluate the safety and tolerability of chronic intermittent use of an investigational medication for 24 or 52 weeks in patients with migraine headaches.
Duration: Up to 58 weeks
Number of visits to CKRA: Up to 13
Compensation: $75.00 per completed clinic visit
Note: Qualified participants must be between the ages of 18 and 65 years old, have at least 2 migraine headaches per month, and must not suffer from chronic migraines or any other chronic headache syndrome. Other criteria also apply.